Capital Performance Advisors’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-138
Closed -$1.75K 2558
2024
Q3
$1.75K Buy
+138
New +$1.75K ﹤0.01% 1626